4.8.1.0: Control of epilepsy

Part of chapter 4 Central Nervous System, section 4.8 Antiepileptic drugs

High-level prescribing trends for Control of epilepsy (BNF section 4.8.1.0) across Brimpton House for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Brivaracetam (0408010AL)
Cannabidiol (0408010AM)
Carbamazepine (0408010C0)
Cenobamate (0408010AN)
Clobazam (040801060)
Clonazepam (0408010F0)
Eslicarbazepine acetate (0408010AI)
Ethosuximide (0408010I0)
Felbamate (0408010AA)
Gabapentin (0408010G0)
Lacosamide (0408010AH)
Lamotrigine (0408010H0)
Levetiracetam (0408010A0)
Mesuximide (0408010K0)
Other Preparations (040801000)
Oxcarbazepine (0408010D0)
Perampanel (0408010AK)
Phenobarbital (0408010N0)
Phenobarbital sodium (0408010P0)
Phenytoin (0408010Z0)
Phenytoin sodium (0408010Q0)
Pregabalin (0408010AE)
Primidone (0408010U0)
Retigabine (0408010AJ)
Rufinamide (0408010AF)
Semisodium Valproate (0408010AC)
Sodium valproate (0408010W0)
Stiripentol (0408010AG)
Sultiame (0408010Y0)
Tiagabine (0408010AB)
Topiramate (040801050)
Valproic acid (040801020)
Vigabatrin (0408010X0)
Zonisamide (0408010AD)
Feedback